Patents by Inventor Sofia Giacosa

Sofia Giacosa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic lethal drug combination for treating renal cell carcinoma
    Patent number: 10322133
    Abstract: The present invention pertains to a novel treatment of renal cell carcinoma and other a solid tumors which harbor a VHL inactivation, based on the combination of a first agent inhibiting a protein kinase CK2 (CK2) and a second agent inhibiting an Ataxia Telangiectasia Mutated (ATM) kinase.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: June 18, 2019
    Assignees: Commissariat a l'Energie Atomique et aux Energies Alternatives, Institut National de la Sante et de la Recherche Medicale
    Inventors: Sofia Giacosa, Catherine Pillet, Claude Cochet, Odile Filhol, Caroline Barette, Emmanuelle Soleilhac
  • A Synthetic Lethal Drug Combination for Treating Renal Cell Carcinoma
    Publication number: 20180256587
    Abstract: The present invention pertains to a novel treatment of renal cell carcinoma and other a solid tumors which harbor a VHL inactivation, based on the combination of a first agent inhibiting a protein kinase CK2 (CK2) and a second agent inhibiting an Ataxia Telangiectasia Mutated (ATM) kinase.
    Type: Application
    Filed: September 21, 2016
    Publication date: September 13, 2018
    Applicants: Commissariat a l'Energie Atomique et aux Energies Alternatives, Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Sofia Giacosa, Catherine Pillet, Claude Cochet, Odile Filhol, Caroline Barette, Emmanuelle Soleilhac